Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorSobczak, Amélie I. S.
dc.contributor.authorPitt, Samantha J.
dc.contributor.authorStewart, Alan J.
dc.date.accessioned2018-08-28T15:30:05Z
dc.date.available2018-08-28T15:30:05Z
dc.date.issued2018-09
dc.identifier255043324
dc.identifier8b319b17-52a5-4b8b-982b-c435c2c99d43
dc.identifier85053909110
dc.identifier000448418000001
dc.identifier.citationSobczak , A I S , Pitt , S J & Stewart , A J 2018 , ' Influence of zinc on glycosaminoglycan neutralisation during coagulation ' , Metallomics , vol. 10 , no. 9 , pp. 1180-1190 . https://doi.org/10.1039/C8MT00159Fen
dc.identifier.issn1756-5901
dc.identifier.urihttps://hdl.handle.net/10023/15895
dc.descriptionThis work was supported by the British Heart Foundation (grant codes: PG/15/9/31270 and FS/15/42/31556). SJP is supported by a Royal Society of Edinburgh Biomedical Fellowship.en
dc.description.abstractHeparan sulfate (HS), dermatan sulfate (DS) and heparin are glycosaminoglycans (GAGs) that serve as key natural and pharmacological anticoagulants. During normal clotting such agents require to be inactivated or neutralised. Several proteins have been reported to facilitate their neutralisation, which reside in platelet α-granules and are released following platelet activation. These include histidine-rich-glycoprotein (HRG), fibrinogen and high-molecular-weight kininogen (HMWK). Zinc ions (Zn2+) are also present in α-granules at a high concentration and participate in the propagation of coagulation by influencing the binding of neutralising proteins to GAGs. Zn2+ in many cases increases the affinity of these proteins to GAGs, and is thus an important regulator of GAG neutralisation and haemostasis. Binding of Zn2+ to HRG, HMWK and fibrinogen is mediated predominantly through coordination to histidine residues but the mechanisms by which Zn2+ increases the affinity of the proteins for GAGs are not yet completely clear. Here we will review current knowledge of how Zn2+ binds to and influences the neutralisation of GAGs and describe the importance of this process in both normal and pathogenic clotting.
dc.format.extent11
dc.format.extent1978685
dc.language.isoeng
dc.relation.ispartofMetallomicsen
dc.subjectAnticoagulantsen
dc.subjectBlood clottingen
dc.subjectHeparinen
dc.subjectPlateletsen
dc.subjectZincen
dc.titleInfluence of zinc on glycosaminoglycan neutralisation during coagulationen
dc.typeJournal itemen
dc.contributor.sponsorBritish Heart Foundationen
dc.contributor.sponsorThe Royal Society of Edinburghen
dc.contributor.sponsorBritish Heart Foundationen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.contributor.institutionUniversity of St Andrews. Cellular Medicine Divisionen
dc.contributor.institutionUniversity of St Andrews. Biomedical Sciences Research Complexen
dc.contributor.institutionUniversity of St Andrews. Institute of Behavioural and Neural Sciencesen
dc.identifier.doi10.1039/C8MT00159F
dc.description.statusPeer revieweden
dc.identifier.urlhttps://europepmc.org/articles/PMC6148461en
dc.identifier.grantnumberFS/15/42/31556en
dc.identifier.grantnumberen
dc.identifier.grantnumberPG/15/9/31270en


This item appears in the following Collection(s)

Show simple item record